The results showed that CASP12 expression was significantly associated with differentiation, lymph node metastasis, tumor size, FIGO staging and clinical outcomes (P<0.05), but not with age, HPV types and pathological types (P>0.05). The gene discussed is CASP12; the disease is neoplasm.